Literature DB >> 33339127

Lysophosphatidic Acid Signaling in Cancer.

David N Brindley1,2.   

Abstract

This Special Issue aims to highlight the impact of discoveries made over the last 25 years on the role of autotaxin (ATX) and lysophosphatidic acid (lysophosphatidate, LPA) signaling in tumor growth, metastasis and the treatment of cancers by chemotherapy, radiotherapy and immunotherapy [...].

Entities:  

Year:  2020        PMID： 33339127     DOI： 10.3390/cancers12123791

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN： 2072-6694            Impact factor:   6.639


  3 in total

1.  Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer.

Authors:  Chang-Suk Chae; Tito A Sandoval; Sung-Min Hwang; Eun Sil Park; Paolo Giovanelli; Deepika Awasthi; Camilla Salvagno; Alexander Emmanuelli; Chen Tan; Vidyanath Chaudhary; Julia Casado; Andrew V Kossenkov; Minkyung Song; Franck J Barrat; Kevin Holcomb; E Alfonso Romero-Sandoval; Dmitriy Zamarin; David Pépin; Alan D D'Andrea; Anniina Färkkilä; Juan R Cubillos-Ruiz
Journal:  Cancer Discov       Date:  2022-08-05       Impact factor: 38.272

2.  Lowering of lysophosphatidylcholines in ovariectomized rats by Curcuma comosa.

Authors:  Jetjamnong Sueajai; Nareerat Sutjarit; Nittaya Boonmuen; Saranya Auparakkitanon; Nantida Noumjad; Apichart Suksamrarn; Nawaporn Vinayavekhin; Pawinee Piyachaturawat
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.240

3.  Association between the Expression Levels of MicroRNA-101, -103, and -29a with Autotaxin and Lysophosphatidic Acid Receptor 2 Expression in Gastric Cancer Patients.

Authors:  Sara Tutunchi; Saeedeh Akhavan; Ghodratollah Panahi; Mina Zare; Amirnader Emami Razavi; Reza Shirkoohi
Journal:  J Oncol       Date:  2022-04-11       Impact factor: 4.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.